Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1151-1160 of 1,298) with videos related to

Pageof 130
Sort By:
Nature Communications|November 17, 2020
Transient commensal clonal interactions can drive tumor metastasisSuha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors, et al.
Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resectionXiuning Le, Frederico O Gleber-Netto, M Laura Rubin, et al.
Oncogene|November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathV W Y Lui, E Y L Wong, K Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancerU A Matulonis, G M Wulf, W T Barry, et al.
Cell Reports|August 22, 2019
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic ReprogrammingRaquel Buj, Chi-Wei Chen, Erika S Dahl, et al.
Genome Medicine|August 27, 2019
Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell linesHang Ruan, Yu Xiang, Junsuk Ko, et al.
Cancer & Metabolism|November 28, 2013
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsJulia Billiard, Jennifer B Dennison, Jacques Briand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot StudyAustin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Pageof 130

Showing results (1151-1160 of 1,298) with videos related to

Sort By:
Pageof 130
Nature Communications|November 17, 2020
Transient commensal clonal interactions can drive tumor metastasisSuha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors, et al.
Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resectionXiuning Le, Frederico O Gleber-Netto, M Laura Rubin, et al.
Oncogene|November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathV W Y Lui, E Y L Wong, K Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancerU A Matulonis, G M Wulf, W T Barry, et al.
Cell Reports|August 22, 2019
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic ReprogrammingRaquel Buj, Chi-Wei Chen, Erika S Dahl, et al.
Genome Medicine|August 27, 2019
Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell linesHang Ruan, Yu Xiang, Junsuk Ko, et al.
Cancer & Metabolism|November 28, 2013
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsJulia Billiard, Jennifer B Dennison, Jacques Briand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot StudyAustin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Pageof 130